BofA lowered the firm’s price target on AMN Healthcare (AMN) to $18 from $20 and keeps an Underperform rating on the shares. While hospital fundamentals should remain solid in the second half, the firm is concerned that the policy and reimbursement environment will be more negative compared to recent years, says the analyst, who prefers post-acute over hospitals as the least exposed to the upcoming cuts given this backdrop. The firm is updating estimates and price targets for several companies in its health care facilities coverage.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMN:
- AMN Healthcare price target lowered to $22 from $33 at Citizens JMP
- AMN Healthcare’s Mixed Earnings Call: Strong Performance Amid Challenges
- AMN Healthcare price target lowered to $22 from $27 at BMO Capital
- AMN Healthcare Services: Hold Rating Maintained Amid Weaker Demand and Uncertain Recovery
- AMN Healthcare Reports Q2 2025 Financial Results